Impact of body mass index (BMI) on efficacy and safety of abemaciclib in breast cancer patients (pts) treated in the monarchE trial.

Desmedt, ChristineBorgquist, SigneGarcia-Estevez, LauraMartin, MiguelJohnston, Stephen R. D.Cardoso, FatimaBrufsky, Adam2026-04-042026-04-0420250732-183X1527-7755https://doi.org/10.1200/JCO.2025.43.16_suppl.520https://hdl.handle.net/11616/108906[No abstract available]eninfo:eu-repo/semantics/closedAccessImpact of body mass index (BMI) on efficacy and safety of abemaciclib in breast cancer patients (pts) treated in the monarchE trial.Conference Object4316_SUPPL10.1200/JCO.2025.43.16_suppl.520WOS:001608775300001Q10000-0002-5223-5579